Keywords: intermune, market, actimmune, japan, additional, indications, pharmaceuticals

InterMune to market Actimmune in Japan for additional indications

Article | 10 August 2000

InterMune Pharmaceuticals has licensed the Japanese rights toGenentech's Actimmune (interferon gamma-1b) for the treatment and prevention of infectious diseases ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Actimmune

Interferon Gamma 1 b

Go to drug listing